Where Does Edgewise Therapeutics Inc (EWTX) Stock Fall in the Biotechnology Field After It Has Fallen -6.18% This Week?

Edgewise Therapeutics Inc (EWTX) is near the bottom in its industry group according to InvestorsObserver. EWTX gets an overall rating of 35. That means it scores higher than 35 percent of stocks. Edgewise Therapeutics Inc gets a 27 rank in the Biotechnology industry. Biotechnology is number 46 out of 148 industries.

EWTX has an Overall Score of 35. Find out what this means to you and get the rest of the rankings on EWTX!

See Full EWTX Report

What do These Ratings Mean?

Searching for the best stocks to invest in can be difficult. There are thousands of options and it can be confusing on what actually constitutes a great value. InvestorsObserver allows you to choose from eight unique metrics to view the top industries and the best performing stocks in that industry. A score of 35 would rank higher than 35 percent of all stocks. This ranking system incorporates numerous factors used by analysts to compare stocks in greater detail. This allows you to find the best stocks available in any industry with relative ease. These percentile-ranked scores using both fundamental and technical analysis give investors an easy way to view the attractiveness of specific stocks. Stocks with the highest scores have the best evaluations by analysts working on Wall Street.

What's Happening With Edgewise Therapeutics Inc Stock Today?

Edgewise Therapeutics Inc (EWTX) stock is lower by -0.16% while the S&P 500 is up 0.51% as of 12:03 PM on Friday, Dec 1. EWTX has fallen -$0.01 from the previous closing price of $6.08 on volume of 259,987 shares. Over the past year the S&P 500 has gained 12.63% while EWTX has fallen -29.25%. EWTX lost -$1.41 per share the over the last 12 months. Click Here to get the full Stock Report for Edgewise Therapeutics Inc stock.